HSY
40
2
MS
64
7
TAP
45
-6
NKE
46
12
OMC
64
-2
PGR
68
3
RF
51
-2
CCL
68
-4
A
44
-2
NI
65
2
EOG
42
-8
UPS
55
-6
HAS
55
-2
AIV
71
9
T
56
2
PSA
66
3
PPL
65
6
UNP
40
-2
PSX
40
-4
LH
48
-2
HSY
40
2
MS
64
7
TAP
45
-6
NKE
46
12
OMC
64
-2
PGR
68
3
RF
51
-2
CCL
68
-4
A
44
-2
NI
65
2
EOG
42
-8
UPS
55
-6
HAS
55
-2
AIV
71
9
T
56
2
PSA
66
3
PPL
65
6
UNP
40
-2
PSX
40
-4
LH
48
-2
Financhill
Back

Commonwealth Bank of Australia Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
44

CMWAY
Commonwealth Bank of Australia

Last Price:
97.70
Seasonality Move:
4.54%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
44
Commonwealth Bank of Australia (CMWAY) is a Sell

Is Commonwealth Bank of Australia a Buy, Sell or Hold?

  • The current Commonwealth Bank of Australia [CMWAY] share price is $97.70. The Score for CMWAY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CMWAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CMWAY Stock Price Chart

What is Commonwealth Bank of Australia's stock price today?

  • The Commonwealth Bank of Australia share price today is $97.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMWAY is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CMWAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.88 Buy
Relative Strength Index (14 RSI): 62.29 Buy
Chaikin Money Flow: 450 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.58 - 96.78) Buy
Bollinger Bands (100): (80.3 - 92.66) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CMWAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.81 Buy
20-day SMA: 95.62 Buy
50-day SMA: 91.26 Buy
200-day SMA: 81.02 Buy
8-day EMA: 96.98 Buy
20-day EMA: 95.37 Buy
50-day EMA: 91.82 Buy
200-day EMA: 82.31 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Commonwealth Bank of Australia Earnings Growth & CMWAY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.03 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Commonwealth Bank of Australia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):